Bryce Point Capital’s Globus Medical GMED Stock Holding History

Bryce Point Capital’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-6,937	Closed	-$574K	–	290
2024 Q4	$574K	Buy	+6,937	New	+$547K	0.17%	172

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bryce Point Capital's GMED Position: Q1 2025 in Review

Bryce Point Capital sold out of Globus Medical (GMED) in Q1 2025, closing a stake of 6,937 shares — an estimated $574K sold.

Bryce Point Capital first reported a position in GMED in Q4 2024 and held it in 1 quarter. The position peaked at $574K in Q4 2024. 514 funds tracked by Wall St. Rank hold GMED as of Q1 2025.

Bryce Point Capital reported no remaining Globus Medical position as of Q1 2025 after selling out during the quarter.
Bryce Point Capital sold 6,937 Globus Medical shares in Q1 2025, an estimated $574K.
Bryce Point Capital first reported a position in Globus Medical in Q4 2024 and held it in 1 quarter.
Bryce Point Capital's Globus Medical position peaked at $574K in Q4 2024.
514 funds tracked by Wall St. Rank held Globus Medical as of Q1 2025.

Based on Bryce Point Capital's 13F filing for Q1 2025, filed 7 May 2025.